Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Outcomes for Patients with Generalized Myasthenia Gravis Prescribed Ravulizumab or Efgartigimod Treatment: A Retrospective Medical Record Analysis

              Author:Scheiner, Christopher   Macwan, Samir   Streicher, Nicholas   Yee, Karen   Sader, Chloe   Blackowicz, Michael   Numapau, Nana   Gentile, Danielle   Sharpe, Jason   Pathak, Prathamesh   Pulley, Michael   

              Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P1.001  

              Author Institution:University of Tennessee Medical Center, Knoxville, TN  Eisenhower Health Center, Rancho Mirage, CA  MedStar Georgetown University Hospital, UT Neurology, Washington, DC  Alexion, AstraZeneca Rare Disease, Boston, MA  Cardinal Health, Dublin, OH  University of Florida College of Medicine, Jacksonville, FL  

              Assessment of Hospitalizations in Patients with Generalized Myasthenia Gravis (gMG) Before and During Treatment with Ravulizumab: Results from a Global Registry

              Author:Tandan, Rup   Macwan, Samir   Winkley, James   Scheiner, Christopher   Nicolle, Michael   Zeinali, Lida   Liu, Chuang   Cutter, Gary   Habib, Ali   Pulley, Michael   

              Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P1.016  

              Author Institution:University of Vermont Medical Center, Burlington, VT  Eisenhower Health Center, Rancho Mirage, CA  Baptist Health Medical Group Neurology, Lexington, KY  University of Tennessee Medical Center, Knoxville, TN  London Health Sciences Centre, London, ON, Canada  Alexion, AstraZeneca Rare Disease, Mississauga, ON, Canada  Alexion, AstraZeneca Rare Disease, Baar, Switzerland  University of Alabama at Birmingham, Birmingham, AL  University of California, Irvine, Irvine, CA  University of Florida, Jacksonville, FL  

              Change in Concomitant Immunosuppressive Therapies for Generalized Myasthenia Gravis in Patients Receiving Complement C5 Inhibitor Therapies: A Retrospective Analysis of Registry Data

              Author:Nowak, Richard   Habib, Ali   Scheiner, Christopher   Zeinali, Lida   Pulley, Michael   Liu, Chuang   Gordon, Andrew   Narayanaswami, Pushpa   

              Session Name:P7: Neuromuscular and Clinical Neurophysiology (EMG): Neuromuscular Junction Disorders 1  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P7.028  

              Author Institution:Yale School of Medicine, New Haven, CT  University of California, Irvine, Irvine, CA  University of Tennessee Medical Center, Knoxville, TN  Alexion, AstraZeneca Rare Disease, Mississauga, ON, Canada  University of Florida, Jacksonville, FL  Alexion, AstraZeneca Rare Disease, Baar, Switzerland  Northwest Neurology, Ltd., Lake Barrington, IL  Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA